R&D | April 15, 2026
Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
A major highlight of the event was the launch of several publications and digital initiatives, including a certification course on the Ayush Grid portal
Recognition across subsidiaries and geographies highlights pharma major’s focus on inclusive culture, employee experience, and global workforce development
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
Enthral.ai’s platform integrates AI-driven capabilities with compliance-first architecture, enabling automated training workflows
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
The first of four planned modules at the new plant is expected to come online by summer 2026
Subscribe To Our Newsletter & Stay Updated
